Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 Dose Finding completed with no dose limiting toxicities and preliminary recommended Phase 2 dose (RP2D) identified 5 of 7 best overall response evaluable patients achieved ORR (3 CR, 1 CRh and 1 morphologic leukemia-free state) across all dose cohorts, including 1 CR and 1 CRh in 3 patients in preliminary RP2D cohort Announces certain preliminary first quarter 2025 financial results and provides pipeline update SOUTH S ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chairman, President and Chief Executive Officer Bernard Birkett - Senior Vice President and Chief Financial Officer Conference Call Participants Paul Knight - KeyBanc Larry Solow - CJS Securities Justin Bowers - Deutsche Bank Michael Ryskin - Bank of America David Windley - Jefferies Daniel Markowitz - Evercore ISI Thom ...

Core Insights - Fareportal has successfully integrated New Distribution Capability (NDC) with Frontier Airlines, enhancing the travel booking experience for customers [1][3] - Customers booking travel on Frontier through CheapOair or OneTravel can now select seats, purchase bags, and access the best available fares, along with self-service tools for managing travel plans [2][3] Fareportal Overview - Fareportal operates online travel agency brands CheapOair and OneTravel, connecting travelers to over 500 airlines, a million lodging options, and hundreds of car rental providers globally [4] - The company focuses on providing a seamless booking experience through various platforms, including mobile apps and live chat [4] Frontier Airlines Overview - Frontier Airlines is recognized as a leading ultra-low-cost carrier, offering a wide range of domestic and international destinations [3][5] - The airline has introduced new product offerings, including UpFront PlusSM seating and plans to offer First Class seating starting in late 2025 [3] - Frontier Airlines has the largest and youngest A320neo family fleet in the U.S. and was awarded North American Environmental Sustainability Airline of the Year in 2024 [5]

Clermont-Ferrand – April 24, 2025 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELINFinancial information for the three months ended March 31, 2025 Group sales were down 1.9% due to lower Original Equipment volumes, partly offset by a significantly improved mix. In a highly volatile environment shaped by geopolitical and macro-economic uncertainties, the Group tightens up its steering and keeps its 2025 guidance unchanged. Consolidated sales for the quarter down 1.9% at €6.5 billion Volumes were down 7.3% due t ...

NEEDHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that an abstract was accepted for an oral presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30 to June 3, 2025, in Chicago, IL. The oral presentation will feature data from the Company’s phase ...

1、 适度的乐观才是对的。而在这个前提下，你必须学会选择自己的战场。 2、 从投资回报的角度看，我在过去二十年中作为 Founders Fund创始合伙人尝试过的各类投资里， 表现最差的两个领域，就是教育软件和医疗信息化。 3、 当所有人都认同这是一件 "显而易见的大事"时，如果你不能拿出一种完全不同的视角，你就几乎 没戏。 两人多年好友，对话没有太多寒暄，直接切入问题本身： "在一个越来越多系统坏掉的时代，聪明人该怎么选择战场？" 他吐槽了很多美国政府系统失灵的、不可思议之处。比如 地铁 ， 美国修建 1 英里 需要 10 亿美元， 10倍于伦敦搭建的成本；政 府预算明面上写着 "援助非洲"，实际上却是给政党选举买单 …… 反倒是那些不那么热门、但你有独特认知差的地方，更容易挖出真正的机会。 4、 你不能什么都干。你不能像一个冲浪者，在一个没有浪的平静日子里拼命划水。 你要等到有浪来的时候，在恰当的位置发力 ，才会有效果。 彼得 ·蒂尔（Peter Thiel） 在中国 最广为人知的身份，可能是《从 0到1》 的 作者，是支持特朗普的 硅谷少数派，是与马斯克曾在 PayPal一起打天下的早期合伙人。 他是 ...

Core Insights - HII hosted leaders from HD Hyundai Heavy Industries to advance their joint goals outlined in a recent memorandum of understanding, focusing on identifying near-term opportunities and enhancing ship production processes [1][4] Company Collaboration - The visit was part of ongoing discussions between HII and its international partners, showcasing the capabilities of Ingalls Shipbuilding in supporting national security and exchanging best practices [2][4] - HII and HHI aim to leverage their combined expertise to drive technological innovation, improve production efficiency, and strengthen the global defense industry [4] Technological Advancements - The tour included a visit to Ingalls' new virtual welding lab, which enhances the skills of current and future shipbuilders and sets a new benchmark for technology in workforce training [2][4] Company Overview - HII is recognized as the largest military shipbuilder in the U.S., with over 135 years of history in advancing national security, providing capabilities that range from ships to unmanned systems and cyber solutions [6][7]

Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, has issued a letter to shareholders from CEO, Dave Rosa. Dear Shareholders, In recent months, NeuroOne has achieved sever ...

舌尖上的便捷： 2024方便食品行业全景洞察 ⚫ 行业背景与发展趋势：随着全球化和城市化进程的加快，人们生活节奏变快，对便 捷、快速的食品需求日益增长。方便食品因其易于储存、快速食用的特点，成为现 代生活中不可或缺的一部分。 ⚫ 白皮书目的与研究范围：本白皮书旨在分析方便食品行业的当前状况、未来趋势以 及面临的挑战，并探讨如何利用数字化工具进行市场调研和决策支持。 ⚫ 敏捷洞察数字化调研平台简介：敏捷洞察是一个利用在线调研、大数据和人工智能 技术，为企业提供即时市场洞察和消费者行为分析的数字化调研平台。 方便食品的定义 | | 传统方便食品 | | 新兴方便食品 | 健康方便食品 | 特色方便食品 | | --- | --- | --- | --- | --- | --- | | ○ | 方便面：预包装的面条， | ○ | 自热食品：包含自热包的 | ○ 营养代餐：为满足特定营 | ○ 地方特色小吃：模拟地方 | | | 通常附带调味料包，通过 | | 方便食品，如自热火锅、 | 养需求设计的方便食品， | 特色小吃风味的方便食品， | | | 加热水即可食用。 | | 自热米饭等，无需外部热 | 如代餐奶昔 ...

Core Viewpoint - Oragenics, Inc. has submitted a clinical trial protocol for its neurosteroid therapy ONP-002 to the Health and Disability Ethics Committee in New Zealand, marking a significant step in the development of treatments for mild traumatic brain injury (mTBI) or concussion [1][2][3] Company Overview - Oragenics, Inc. is a biotechnology company focused on developing intranasal therapeutics for neurological disorders, with ONP-002 as its lead candidate for treating mTBI or concussion [4] - The company is also advancing proprietary powder formulations and intranasal delivery technology to enhance drug administration [4] Clinical Trial Details - The Phase II clinical trial for ONP-002 aims to evaluate its efficacy in treating mTBI or concussion, with patient enrollment planned in both Australia and New Zealand [2][3] - The trial will be conducted at Christchurch Hospital, the largest tertiary, teaching, and research hospital on New Zealand's South Island, which treats over 83,000 patients annually [2][3] Treatment Significance - There are currently no pharmaceutical therapies available for treating concussion, highlighting an unmet medical need [3] - ONP-002 is designed for intranasal administration, providing a non-invasive and efficient route for drug delivery to the brain, and has shown promising results in preclinical models [3]